IGF1R Protein Expression is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2-positive Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831
- Citation:
- Clin Cancer Res vol 23 (15) 4203-11
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- 581
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U24CA196171
- Corr. Author:
- Authors:
- Monica M. Reinholz Beiyun Chen Amylou C. Dueck Kathleen Tenner Karla Ballman Darren Riehle Robert B. Jenkins Xochiquetzal J. Geiger Ann E McCullough Edith A. Perez
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: